aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
(NASDAQ: ATYR) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $ 
Open $0.40    52 Week Low $ 
Day High $0.40    P/E N/A 
Day Low $0.37    EPS $ 
Volume 999,386